investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Piro Lito

Elucidating the regulation of mitosis by BRAF V600E in lung cancer

Trachea, bronchus and lung

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Trachea, bronchus and lung

Radiation Oncology

Susan Bates

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

Trachea, bronchus and lung

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

Bingliang Fang

Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing

Trachea, bronchus and lung

A. Mcgarry Houghton

IRS-1 Regulates Inflammatory Cell Recruitment in Lung Cancer

Trachea, bronchus and lung

Roy A Jensen

e-Decidete: Mobile Cessation Support for Latino Smokers in Mexico

Trachea, bronchus and lung

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Michele Carbone

Germline BAP1 Mutations and Malignant Mesothelioma: Mechanisms and Early Detection

Trachea, bronchus and lung

Pathology